Abstract:Abstract As part of the safety assessment of salicylate esters in cosmetics, we developed a metabolism factor based on in vitro to in vivo extrapolation (IVIVE) to provide a better estimation of the aggregate internal exposure to the common metabolite, salicylic acid. Optimal incubation conditions using human liver S9 were identified before measuring salicylic acid formation from 31 substances. Four control substances, not defined as salicylic esters but which could be mistaken as such due to their nomenclature, did not form salicylic acid. For the remaining substances, higher in vitro intrinsic clearance (CL int, in vitro ) values generally correlated with lower LogP values. A “High-Throughput Pharmacokinetic” (HTPK) model was used to extrapolate CL int, in vitro values to human in vivo clearance and half-lives. The latter were used to calculate the percentage of substance metabolised to salicylic acid in 24 h in vivo following human exposure to the ester, i.e. the “metabolism factor”. The IVIVE model correctly reproduced the observed elimination rate of 3 substances using in silico or in vitro input parameters. For other substances, in silico only-based predictions generally resulted in lower metabolism factors than when in vitro values for plasma binding and liver S9 CL int, in vitro were used. Therefore, in vitro data input provides the more conservative metabolism factors compared to those derived using on in silico input. In conclusion, these results indicate that not all substances contribute equally (or at all) to the systemic exposure to salicylic acid. Therefore, we propose a realistic metabolism correction factor by which the potential contribution of salicylate esters to the aggregate consumer exposure to salicylic acid from cosmetic use can be estimated.

What problem does this paper attempt to address?

This paper aims to solve the problem of safety assessment of salicylate components in cosmetics, especially how to more accurately estimate the in - vivo cumulative exposure amount of salicylic acid after these components are absorbed through the skin and transformed. Specifically, the research team developed a method based on in - vitro - to - in - vivo extrapolation (IVIVE) to determine a metabolic factor for better estimating the in - vivo cumulative exposure amount of salicylic acid. This metabolic factor can help assess the systemic exposure risks of different salicylates in actual use, thereby providing more accurate data support for the safety assessment of cosmetics. ### Research Background Salicylic acid and its ester compounds are widely used in cosmetics. Although the use of salicylic acid itself in cosmetics is considered safe, when multiple products containing salicylates are used simultaneously, the systemic exposure amount of salicylic acid may increase. Therefore, a more accurate method is needed to assess the systemic exposure risks of these compounds in actual use. ### Research Methods 1. **In - vitro Experiments**: - In - vitro incubation experiments were carried out using human liver S9 to measure the rates at which 31 compounds are transformed into salicylic acid in vitro. - The experimental conditions were optimized, especially by adding different concentrations of bovine serum albumin (BSA) in the incubation of lipophilic compounds to reduce non - specific binding and improve solubility. 2. **High - Throughput Pharmacokinetic Model (HTPK)**: - The HTPK model of SimulationsPlus was used to convert the in - vitro intrinsic clearance rate (CLint, in vitro) into the in - vivo clearance rate and half - life. - The metabolic factor was determined by calculating the proportion of compounds transformed into salicylic acid within 24 hours. ### Main Results - **In - vitro Experiment Results**: - Of the 31 tested compounds, 27 were metabolized into salicylic acid, and the metabolic rate was negatively correlated with the LogP value of the compound, that is, the lower the LogP value, the higher the metabolic rate. - No formation of salicylic acid was detected in four control substances (not real salicylates). - **Metabolic Factor**: - Through the HTPK model, the proportion of compounds transformed into salicylic acid within 24 hours, that is, the metabolic factor, was calculated. - The model results showed that different salicylates contribute differently to systemic exposure, and the metabolic factors of some compounds are close to 100%, while those of others are very low. ### Conclusion This study successfully developed a metabolic factor through in - vitro experiments and the HTPK model to more accurately assess the systemic exposure risks of salicylates in cosmetics. This method is helpful for the safety assessment of cosmetics and ensures the safety of consumers. ### Formulas - **In - vitro Half - life Calculation**: \[ t_{1/2}=-\frac{0.693}{k} \] where \( k \) is the slope of the linear regression. - **In - vitro Intrinsic Clearance Rate Calculation**: \[ CL_{\text{int, in vitro}}=\frac{V\times0.693}{t_{1/2}} \] where \( V = 10,000\,\mu L/\text{mg protein} \). - **Conversion of In - vitro Intrinsic Clearance Rate to In - vivo Intrinsic Clearance Rate**: \[ CL_{\text{int, in vivo}}=CL_{\text{int, in vitro}}\times\frac{\text{mg S9 protein}}{\text{g liver}}\times\frac{\text{g liver}}{\text{kg BW}} \] where \( \frac{\text{mg S9 protein}}{\text{g liver}} = 107.3 \) and \( \text{g liver} = 1433 \) g (for a person with a body weight of 70 kg). - **Hepatic Clearance Rate Calculation**: \[ CL_H=\frac{Q_H\cdot R_{\text{bp}}\cdot F_{\text{up}}\cdot CL_{\text{int, in viv}}

In vitro to in vivo extrapolation to derive a metabolism factor for estimating the aggregate exposure to salicylic acid after dermal exposure of its esters

Next generation risk assessment: an ab initio case study to assess the systemic safety of the cosmetic ingredient, benzyl salicylate, after dermal exposure

Use of in vitro ADME methods to identify suitable analogs of homosalate and octisalate for use in a read‐across safety assessment

Effect of vehicle on the in vitro penetration and metabolism of genistein and daidzein in ex vivo skin explants and the Phenion full‐thickness skin model

The estrogenic potential of salicylate esters and their possible risks in foods and cosmetics.

In vitro to in vivo extrapolation and high-content imaging for simultaneous characterization of chemically induced liver steatosis and markers of hepatotoxicity

Reduced estrogenic risks of a sunscreen additive: Theoretical design and evaluation of functionally improved salicylates

A new conceptional model for deriving average dermal absorption estimates from studies with multiple tested concentrations for non-dietary risk assessment of pesticides

Toxicokinetics of 2-ethylhexyl salicylate (EHS) and its seven metabolites in humans after controlled single dermal exposure to EHS

Toxicokinetics of homosalate in humans after dermal application: applicability of oral-route data for exposure assessment by human biomonitoring

Impact of gut permeability on estimation of oral bioavailability for chemicals in commerce and the environment

In-vitro and in-vivo metabolism of different aspirin formulations studied by a validated liquid chromatography tandem mass spectrometry method

Percutaneous absorption of steroids from finite doses: Predicting urinary excretion from in vitro skin permeation testing

Virtual screening study for biological activity assessment and metabolism pathway of a fuel dye in airborne exposure scenario

Stability of UV filter 2-ethylhexyl salicylate and its glucuronide in human urine – A challenge for robust human biomonitoring

Characterization of the in vitro penetration and first‐pass metabolism of genistein and daidzein using human and pig skin explants and Phenion full‐thickness skin models

Human skin absorption of three plasticizers: Diisononyl-1,2-cyclohexanedicarboxylate (DINCH), di(2-ethylhexyl) terephthalate (DEHTP), and di(2-ethylhexyl) adipate (DEHA)

Artificial Intelligence That Predicts Sensitizing Potential of Cosmetic Ingredients with Accuracy Comparable to Animal and In Vitro Tests—How Does the Infotechnomics Compare to Other “Omics” in the Cosmetics Safety Assessment?

In Vitro Human Dermal Absorption Studies on Pesticides in Complex Mixtures: Investigation of Guidance Criteria and Possible Impact Parameters

Approach for extrapolating in vitro metabolism data to refine bioconcentration factor estimates

Quantum-Mechanics Calculations Elucidate Skin-Sensitizing Pharmaceutical Compounds